Subglottic Stenosis Overview

Save information for later
Sign Up

Learn About Subglottic Stenosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Subglottic Stenosis Local Doctors?
Elite in Subglottic Stenosis
Otolaryngology
Elite in Subglottic Stenosis
Otolaryngology
200 1st St Sw, 
Rochester, MN 
Languages Spoken:
English

Jan Kasperbauer is an Otolaryngologist in Rochester, Minnesota. Dr. Kasperbauer is rated as an Elite provider by MediFind in the treatment of Subglottic Stenosis. His top areas of expertise are Subglottic Stenosis, Anaplastic Thyroid Cancer, Thyroid Cancer, Thyroidectomy, and Laryngectomy.

Elite in Subglottic Stenosis
Pulmonary Medicine
Elite in Subglottic Stenosis
Pulmonary Medicine

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Eric Edell is a Pulmonary Medicine provider in Rochester, Minnesota. Dr. Edell is rated as an Elite provider by MediFind in the treatment of Subglottic Stenosis. His top areas of expertise are Subglottic Stenosis, Lung Cancer, Lung Nodules, Advanced Bronchoscopy, and Endoscopy. Dr. Edell is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Subglottic Stenosis
Elite in Subglottic Stenosis

Vanderbilt University Medical Center

719 Thompson Ln, 
Nashville, TN 
Languages Spoken:
English, Spanish
Accepting New Patients

Alexander Gelbard is an Otolaryngologist in Nashville, Tennessee. Dr. Gelbard is rated as an Elite provider by MediFind in the treatment of Subglottic Stenosis. His top areas of expertise are Subglottic Stenosis, Perichondritis, Tracheobronchomalacia, Laryngectomy, and Endoscopy. Dr. Gelbard is currently accepting new patients.

What are the latest Subglottic Stenosis Clinical Trials?
Effects of IL-17A Inhibition on Idiopathic Subglottic Stenosis

Summary: The purpose of this phase 2 study is to examine if inhibiting IL-17A activation using the biologic drug Taltz, in idiopathic subglottic stenosis patients will decrease scar fibroblast proliferation therefore reducing or eliminating the need for invasive or repeat surgeries.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Comparison of the Safety and Economics of Translaryngeal Endoscopic Mucosal Injection Versus Ultrasound-Guided Injection of Triamcinolone for the Treatment of Subglottic Stenosis: a Multicenter, Randomized Controlled Study.

Summary: This study employs a multicenter, randomized controlled trial method, where patients meeting the inclusion criteria for subglottic stenosis are randomly divided into two groups. These groups are respectively undergoing translaryngeal endoscopic mucosal injection and ultrasound-guided injection of triamcinolone treatment. The comparison will focus on various indicators such as therapeutic effect, i...